n-pentanoic acid has been researched along with AM2201 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, MH; Carlier, J; Huestis, MA; Salmeron, BD; Scheidweiler, KB; Wohlfarth, A | 1 |
| Auwarter, V; Brandt, SD; Broecker, S; Franz, F; Hutter, M; Kneisel, S | 1 |
2 other study(ies) available for n-pentanoic acid and AM2201
| Article | Year |
|---|---|
Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry.
Topics: Animals; Cannabinoids; Chromatography, Liquid; Humans; Indoles; Naphthalenes; Pentanoic Acids; Rats; Tandem Mass Spectrometry | 2016 |
Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
Topics: Cannabinoid Receptor Agonists; Cannabinoids; Chromatography, Liquid; Humans; Indoles; Naphthalenes; Pentanoic Acids; Substance Abuse Detection; Tandem Mass Spectrometry | 2018 |